BioNTech SE - ADR
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About BioNTech SE - ADR
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.
/ 
Frequently asked questions
To buy BioNTech SE - ADR stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for BioNTech SE - ADR by name or ticker, choose the number of shares, and place your order.
The ticker symbol for BioNTech SE - ADR is 22UA:xetr. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
BioNTech SE - ADR has its primary listing on Deutsche Börse (XETRA). You can trade BioNTech SE - ADR with a Saxo account, alongside thousands of other stocks worldwide.
Yes, BioNTech SE - ADR is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include BioNTech SE - ADR as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like BioNTech SE - ADR.